eli lilly compounded tirzepatide uk versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to Eli Lilly warns against compounding

Furthermore, the KDIGO 2024 guidelines cover combination therapy from the perspective of SGLT2is being first-line therapy, and long-acting GLP-1 RAs being an add-on in adults with CKD and T2D who have not achieved individualised glycaemic targets despite use of metformin and SGLT2is, or who are unable to use those medications [2]

Ethics declarations Conflict of interest KE has been member on advisory boards for Eli Lilly & Co., NovoNordisk, Lifescan, Roche, GSK, Bayer and has received honoraria from these activities

Anergic T cells are metabolically anergic

Wharton hopes both oral drugs will be available to consumers by 2026, though that depends how quickly they move through the FDAs approval process